FDA Approves First Self-Administered Flu Vaccine

The FDA has approved the first self-administered flu vaccine, offering a new option to increase flu vaccination accessibility. Adults can now administer FluMist, a nasal spray vaccine, at home without a healthcare provider present. This option may help address the decline in flu vaccination rates, which fell below 50% during the 2022-2023 season.

 

Available for those aged 2 to 49, FluMist provides a convenient alternative to traditional flu shots. However, individuals must still obtain a prescription, and vaccines will be delivered directly to homes. This innovation could enhance public health efforts by improving access to seasonal flu prevention. Read more from The Hill here.